Absci Corporation Common Stock

ABSINASDAQ • USD
ThemeAI & Machine Learning›AI Platforms & Infrastructure
10.27 USD
↘ 1.26 (10.90%)AT CLOSE (03:59 PM EDT)
10.32
↗ 0.05 (0.49%)
POST MARKET (AS OF 06:09 PM EDT)
Post Market
AS OF 06:09 PM EDT
10.32
↗ 0.05 (0.49%)
🟢Market: OPEN

ABSI is currently priced at $10.32. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, ABSI trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Oct 6, 2026.

Open?$11.77
High?$11.89
Low?$10.21
Prev. Close?$11.53
Volume?5.9M
Avg. Volume?3.7M
VWAP?$10.72
Rel. Volume?1.58x
Bid / Ask
Bid?$8.96 × 100
Ask?$12.04 × 100
Spread?$3.08
Midpoint?$10.50
Valuation & Ratios
Market Cap?2.0B
Shares Out?171.6M
Float?119.4M
Float %?69.6%
P/E Ratio?N/A
P/B Ratio?8.04
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Themes
AI & Machine Learning›AI Platforms & InfrastructureBiotech - Drug Development›Clinical-Stage Platforms
Employees
140
Market Cap
2.0B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Website
www.absci.com
Listed
2021-07-22
Address
18105 SE MILL PLAIN BLVD
VANCOUVER, WA 98683
Phone: (360) 949-1041
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
100
Momentum?
50
Short Sent.?
10
Piotroski F-Score?2/9Weak
Altman Z-Score?84.29Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?31.21%Squeeze Risk
Short Interest?37.3M
Days to Cover?14.4
Free Float119.4M
Avg Daily Volume2.6M
Settlement Date2026-09-15
Financial Health
Current Ratio?10.63Strong
Quick Ratio?10.63Strong
Cash Ratio?5.50Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A▾
P/B?
Peers
100
S&P
23
8.04HIGH▾
P/S?
Peers
100
S&P
3
1,267.59HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-16.3CHEAP▾
EV/Sales?
Peers
100
S&P
3
1,198.59HIGH▾
Returns & Efficiency
ROE?
S&P
3
-49.2%WEAK▾
ROA?
S&P
3
-45.0%WEAK▾
Cash Flow & Enterprise
FCF?$-108974000
Enterprise Value?$1.9B
Fundamentals ratios updated end of day
MarketsMoversWatchlist